RETRACTED: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors

BackgroundIn children, Wilms’ tumors are the most common urological cancer with unsatisfactory prognosis, but few molecular prognostic markers have been discovered for it. With the rapid development of high-throughput quantitative proteomic and transcriptomic approaches, the molecular mechanisms of...

Full description

Bibliographic Details
Main Authors: Lei Lou, Luping Chen, Yaohao Wu, Gang Zhang, Ronglin Qiu, Jianhang Su, Zhuangjie Zhao, Zijie Lu, Minyi Liao, Xiaogeng Deng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.982110/full
_version_ 1797257224620343296
author Lei Lou
Lei Lou
Luping Chen
Luping Chen
Yaohao Wu
Gang Zhang
Ronglin Qiu
Jianhang Su
Zhuangjie Zhao
Zijie Lu
Minyi Liao
Xiaogeng Deng
author_facet Lei Lou
Lei Lou
Luping Chen
Luping Chen
Yaohao Wu
Gang Zhang
Ronglin Qiu
Jianhang Su
Zhuangjie Zhao
Zijie Lu
Minyi Liao
Xiaogeng Deng
author_sort Lei Lou
collection DOAJ
description BackgroundIn children, Wilms’ tumors are the most common urological cancer with unsatisfactory prognosis, but few molecular prognostic markers have been discovered for it. With the rapid development of high-throughput quantitative proteomic and transcriptomic approaches, the molecular mechanisms of various cancers have been comprehensively explored. This study aimed to uncover the molecular mechanisms underlying Wilms tumor and build predictive models by use of microarray and RNA-seq data.MethodsGene expression datasets were downloaded from Therapeutically Applicable Research to Generate Effective Treatments (TARGET) and Gene Expression Omnibus (GEO) databases. Bioinformatics methods wereutilized to identified hub genes, and these hub genes were validated by experiment. Nomogram predicting OS was developed using genetic risk score model and clinicopathological variables.ResultsCDC20, BUB1 and CCNB2 were highly expressed in tumor tissues and able to affect cell proliferation and the cell cycle of SK-NEP-1 cells. This may reveal molecular biology features and a new therapeutic target of Wilms tumour.7 genes were selected as prognostic genes after univariate, Lasso, and multivariate Cox regression analyses and had good accuracy, a prognostic nomogram combined gene model with clinical factors was completed with high accuracy.ConclusionsThe current study discovered CDC20,BUB1 and CCNB2 as hub-genes associated with Wilms tumor, providing references to understand the pathogenesis and be considered a novel candidate to target therapy and construct novel nomogram, incorporating both clinical risk factors and gene model, could be appropriately applied in preoperative individualized prediction of malignancy in patients with Wilms tumor.
first_indexed 2024-03-11T17:56:37Z
format Article
id doaj.art-f5d6835d90b04d4a9b4e74b862cddd1a
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-24T22:34:15Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-f5d6835d90b04d4a9b4e74b862cddd1a2024-03-19T13:57:09ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-10-011210.3389/fonc.2022.982110982110RETRACTED: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumorsLei Lou0Lei Lou1Luping Chen2Luping Chen3Yaohao Wu4Gang Zhang5Ronglin Qiu6Jianhang Su7Zhuangjie Zhao8Zijie Lu9Minyi Liao10Xiaogeng Deng11Department of Pediatric Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaDepartment of Pediatric Surgery, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaDepartment of Pediatric Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaDepartment of Pediatric Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaDepartment of Pediatric Surgery, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaDepartment of Pediatric Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaDepartment of Pediatric Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaDepartment of Pediatric Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaDepartment of Pediatric Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaDepartment of Pediatric Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaDepartment of Pediatric Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaBackgroundIn children, Wilms’ tumors are the most common urological cancer with unsatisfactory prognosis, but few molecular prognostic markers have been discovered for it. With the rapid development of high-throughput quantitative proteomic and transcriptomic approaches, the molecular mechanisms of various cancers have been comprehensively explored. This study aimed to uncover the molecular mechanisms underlying Wilms tumor and build predictive models by use of microarray and RNA-seq data.MethodsGene expression datasets were downloaded from Therapeutically Applicable Research to Generate Effective Treatments (TARGET) and Gene Expression Omnibus (GEO) databases. Bioinformatics methods wereutilized to identified hub genes, and these hub genes were validated by experiment. Nomogram predicting OS was developed using genetic risk score model and clinicopathological variables.ResultsCDC20, BUB1 and CCNB2 were highly expressed in tumor tissues and able to affect cell proliferation and the cell cycle of SK-NEP-1 cells. This may reveal molecular biology features and a new therapeutic target of Wilms tumour.7 genes were selected as prognostic genes after univariate, Lasso, and multivariate Cox regression analyses and had good accuracy, a prognostic nomogram combined gene model with clinical factors was completed with high accuracy.ConclusionsThe current study discovered CDC20,BUB1 and CCNB2 as hub-genes associated with Wilms tumor, providing references to understand the pathogenesis and be considered a novel candidate to target therapy and construct novel nomogram, incorporating both clinical risk factors and gene model, could be appropriately applied in preoperative individualized prediction of malignancy in patients with Wilms tumor.https://www.frontiersin.org/articles/10.3389/fonc.2022.982110/fullwilms tumorhub generisk stratificationprognostic modelnomogram
spellingShingle Lei Lou
Lei Lou
Luping Chen
Luping Chen
Yaohao Wu
Gang Zhang
Ronglin Qiu
Jianhang Su
Zhuangjie Zhao
Zijie Lu
Minyi Liao
Xiaogeng Deng
RETRACTED: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
Frontiers in Oncology
wilms tumor
hub gene
risk stratification
prognostic model
nomogram
title RETRACTED: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
title_full RETRACTED: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
title_fullStr RETRACTED: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
title_full_unstemmed RETRACTED: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
title_short RETRACTED: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
title_sort retracted identification of hub genes and construction of prognostic nomogram for patients with wilms tumors
topic wilms tumor
hub gene
risk stratification
prognostic model
nomogram
url https://www.frontiersin.org/articles/10.3389/fonc.2022.982110/full
work_keys_str_mv AT leilou retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors
AT leilou retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors
AT lupingchen retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors
AT lupingchen retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors
AT yaohaowu retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors
AT gangzhang retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors
AT ronglinqiu retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors
AT jianhangsu retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors
AT zhuangjiezhao retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors
AT zijielu retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors
AT minyiliao retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors
AT xiaogengdeng retractedidentificationofhubgenesandconstructionofprognosticnomogramforpatientswithwilmstumors